9926:HKG
Akeso Inc
HK$ 91.30
arrow_upward
+0.94%(+0.85) 1D
10-р сарын 16, 16:08:14 (GMT+8) · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$ 92.15
High
HK$ 95.30
Low
HK$ 90.15
Mkt. cap
84.10 тэрбум
Avg. vol.
10.45 сая
Volume
11.09 сая
52-wk high
HK$ 156.00
52-wk low
HK$ 80.20
EPS
-HK$ 1.24
No. of employees
4 мян
Open
HK$ 92.15
High
HK$ 95.30
Low
HK$ 90.15
Mkt. cap
84.10 тэрбум
Avg. vol.
10.45 сая
Volume
11.09 сая
52-wk high
HK$ 156.00
52-wk low
HK$ 80.20
EPS
-HK$ 1.24
No. of employees
4 мян
News stories
From web sources and news partners
TradingView
·
1 цагийн өмнө
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
The Fintech Times
·
28 минутын өмнө
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
1 цагийн өмнө
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
·
4 цагийн өмнө
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08 мян
Founded2012 оны 3-р сарын 19
Headquarters-
Sector-
Websiteakesobio.com